feed,title,long_url,short_url
Investors,"Roku Stock Plunges On Big Loss, Sales Miss, Weak Outlook",https://www.investors.com/news/technology/roku-stock-plunges-on-big-loss-sales-miss-weak-outlook/,https://bit.ly/3Q2vtz1
Investors,Cybersecurity Palo Alto Networks Stock Shows Rising Relative Strength,https://www.investors.com/news/technology/cybersecurity-palo-alto-networks-stock-shows-rising-relative-strength/,https://bit.ly/3zoR5z4
Investors,Stock Market Today: Track Market Trends And The Best Stocks To Watch,https://www.investors.com/news/stock-market-today-market-trends-best-stocks-buy-watch/,https://bit.ly/3JjLDSn
Investors,Top-Rated Stocks: Acadia Healthcare Sees Composite Rating Climb To 96,https://www.investors.com/news/top-rated-stocks-acadia-healthcare-sees-composite-rating-climb-to-96/,https://bit.ly/3zaU2Tq
Investors,Apple Stock Nears Buy Point After 'Top Gun'-Style June Quarter,https://www.investors.com/news/technology/apple-stock-nears-buy-point-after-top-gun-style-june-quarter/,https://bit.ly/3bjAxAs
Investors,"Despite A Quarterly Loss, Wall Street Satisfied With Amazon Report",https://www.investors.com/news/technology/amazon-stock-soars-in-reaction-to-earnings-report/,https://bit.ly/3PDMTSN
Investors,"Fueling Carbon Capture In the Oil Industry: Production, Net Zero And ESG",https://www.investors.com/news/carbon-capture-oil-industry-production-net-zero-esg/,https://bit.ly/3zfzlpK
Investors,Meta Faces A Long And Winding Road To Get Out Of A Muddy Morass,https://www.investors.com/news/technology/meta-stock-long-road-out-of-muddy-morass/,https://bit.ly/3POxS0w
Investors,AstraZeneca Expects Flat 2022 Covid Sales â€” Which Is Better Than Expected,https://www.investors.com/news/technology/azn-stock-astrazeneca-earninga-q2-2022/,https://bit.ly/3PZh5aA
Investors,"Stock Market Rally Powers Higher On Fed Rate Hints; Apple, Microsoft, Meta, Amazon, Google Key Earnings: Weekly Review",https://www.investors.com/news/stock-market-rally-powers-higher-on-fed-rate-hints-apple-microsoft-meta-amazon-google-key-earnings/,https://bit.ly/3OL9sn8
Investors,AbbVie Leans On Immunology Drugs To Offset Aesthetic Downturn Amid Covid,https://www.investors.com/news/technology/abbvie-stock-abbv-earnings-q2-2022/,https://bit.ly/3Q9x46h
